Zenotech Laboratories Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales/income from operations of INR 13.815 million, loss from operations before other income, finance costs and exceptional items of INR 40.820 million, loss from ordinary activities before tax of INR 44.566 million, net loss of INR 44.566 million or INR 1.29 per basic and diluted share after extraordinary items. For the nine months period, the company reported net sales/income from operations of INR 28.092 million, loss from operations before other income, finance costs and exceptional items of INR 127.621 million, loss from ordinary activities before tax of INR 137.165 million, net loss of INR 137.165 million or INR 3.98 per basic and diluted share after extraordinary items.

Zenotech Laboratories Limited, Board Meeting, Feb 08, 2013. Agenda: To consider quarterly results.

The shareholders of Zenotech Laboratories Limited at the AGM held on December 28, 2012 not approved the amendment in the Articles of Association of the company.